Sauter, Bernhard

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 6.

Journal Article

Greuter, Thomas; Maillard, Michel H; Juillerat, Pascal; Michetti, Pierre; Seibold, Frank; Mottet, Christian; Zahnd, Nadine; Sauter, Bernhard; Schoepfer, Alain M; Rogler, Gerhard; Vavricka, Stephan R (2020). Therapeutic Drug Monitoring to Guide Clinical Decision Making in Inflammatory Bowel Disease Patients with Loss of Response to Anti-TNF: A Delphi Technique-Based Consensus. Digestion, 101(6), pp. 683-691. Karger 10.1159/000501930

Juillerat, Pascal; Manz, Michael; Sauter, Bernhard; Zeitz, Jonas; Vavricka, Stephan R. (2020). Therapies in Inflammatory Bowel Disease Patients with Extraintestinal Manifestations. Digestion, 101(S1), pp. 83-97. Karger 10.1159/000502816

Godat, Sébastien; Fournier, Nicolas; Safroneeva, Ekaterina; Juillerat, Pascal; Nydegger, Andreas; Straumann, Alex; Vavricka, Stephan; Biedermann, Luc; Greuter, Thomas; Fraga, Montserrat; Abdelrahman, Karim; Hahnloser, Dieter; Sauter, Bernhard; Rogler, Gerhard; Michetti, Pierre; Schoepfer, Alain M; Cohort Study Group, Swiss IBD (2018). Frequency and type of drug-related side effects necessitating treatment discontinuation in the Swiss Inflammatory Bowel Disease Cohort. European journal of gastroenterology & hepatology, 30(6), pp. 612-620. Lippincott Williams & Wilkins 10.1097/MEG.0000000000001078

Sauter, Bernhard; Beglinger, Christoph; Girardin, Marc; Macpherson, Andrew; Michetti, Pierre; Schoepfer, Alain; Seibold, Frank Werner; Vavricka, Stephan R; Rogler, Gerhard (2014). Monitoring disease activity and progression in Crohn's disease. A Swiss perspective on the IBD ahead 'optimised monitoring' recommendations. Digestion, 89(4), pp. 299-309. Karger 10.1159/000360283

Vavricka, Stephan R; Schoepfer, Alain M; Bansky, Georg; Binek, Janek; Felley, Christian; Geyer, Martin; Manz, Michael; Rogler, Gerhard; de Saussure, Philippe; Sauter, Bernhard; Scharl, Michael; Seibold, Frank; Straumann, Alex; Michetti, Pierre; Swiss, IBDnet (2011). Efficacy and safety of certolizumab pegol in an unselected crohn's disease population: 26-week data of the FACTS II survey. Inflammatory bowel diseases, 17(7), pp. 1530-9. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1002/ibd.21521

Schoepfer, Alain M.; Vavricka, Stephan R.; Binek, Janek; Felley, Christian; Geyer, Martin; Manz, Michael; Rogler, Gerhard; de Saussure, Philippe; Sauter, Bernhard; Seibold, Frank; Straumann, Alex; Michetti, Pierre (2010). Efficacy and safety of certolizumab pegol induction therapy in an unselected Crohnʼs disease population. Inflammatory bowel diseases, 16(6), pp. 933-938. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1002/ibd.21127

This list was generated on Fri Mar 29 14:28:00 2024 CET.
Provide Feedback